Unlock stock picks and a broker-level newsfeed that powers Wall Street.

KSE - Delayed Quote KRW

Hanall Biopharma Co., Ltd. (009420.KS)

Compare
27,400.00
+800.00
+(3.01%)
At close: 3:30:23 PM GMT+9

Research Analysis

Revenue vs. Earnings

Revenue 36.42B
Earnings 1.5B

Q1'24

Q2'24

Q3'24

Q4'24

0
10B
20B
30B
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

40,000.00
48,000.00 Average
27,400.00 Current
62,000.00 High

Earnings Estimate

Currency in USD Current Qtr. (Jan 1970)Next Qtr. (Jan 1970)Current Year (2025)Next Year (2026)
No. of Analysts ----67
Avg. Estimate 00156.8609.39
Low Estimate 0010.878.7
High Estimate 004432,379
Year Ago EPS -----36156.8

Revenue Estimate

Currency in USD Current Qtr. (Jan 1970)Next Qtr. (Jan 1970)Current Year (2025)Next Year (2026)
No. of Analysts ----47
Avg. Estimate ----156.22B192.74B
Low Estimate ----153B163B
High Estimate ----164B266.6B
Year Ago Sales ----138.94B156.22B
Sales Growth (year/est) ----12.44%23.38%

EPS Trend

Currency in USD Current Qtr. (Jan 1970)Next Qtr. (Jan 1970)Current Year (2025)Next Year (2026)
Current Estimate 00156.8609.39
7 Days Ago 00199.2590
30 Days Ago 00114.33458
60 Days Ago 00398835.17
90 Days Ago 00398835.17

EPS Revisions

Currency in USD Current Qtr. (Jan 1970)Next Qtr. (Jan 1970)Current Year (2025)Next Year (2026)
Up Last 7 Days ------2
Up Last 30 Days ----11
Down Last 7 Days ----1--
Down Last 30 Days ----22

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
009420.KS ----535.56%288.64%
S&P 500 6.40%6.07%9.36%14.28%